Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Obeticholic acid or its saltsPDL I MAY / 17
ObinutuzumabPDL I DEC / 14
Oclacitinib or its saltsPDL

including but not limited to Oclacitinib maleate

I AUG / 14
OcrelizumabPDL I SEP / 17
OcriplasminPDL I DEC / 13
Octatropine methylbromidePDL I DEC / 13
OctreotidePDL I DEC / 13
OfatumumabPDL I DEC / 13
Ofloxacin or its saltsPDL

including but not limited to levofloxacin

I DEC / 13
Olanzapine or its saltsPDL I DEC / 13
OlaparibPDL I AUG / 16
OlaratumabPDL I MAR / 18
Oleandomycin or its salts or derivativesPDL

For human use.

I DEC / 13
Olmesartan and its salts and derivativesPDL

including but not limited to olmesartan medoxmil

I DEC / 13
Olodaterol or its saltsPDL I DEC / 13
Olopatadine or its saltsPDL I DEC / 13
Olsalazine or its saltsPDL I DEC / 13
OmalizumabPDL I DEC / 13
OmbitasvirPDL I MAR / 15
Omeprazole or its saltsPDL

including but not limited to omeprazole, omeprazole magnesium except when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole for human use

I SEP / 14
Omeprazole or its saltsPDL

For veterinary use including but not limited to omeprazole, omeprazole magnesium

I DEC / 13
Omeprazole or its salts.

when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole

II SEP / 14
Ondansetron or its saltsPDL I DEC / 13
OpiumN I JUN / 02
Orbifloxacin or its salts or derivativesPDL I DEC / 13
Orciprenaline (Metaproterenol) or its saltsPDL I DEC / 13
OrlistatPDL I DEC / 13
Ormetoprim or its saltsPDL I DEC / 13
OrnidazolePDL I DEC / 13
Orphenadrine citrate III SEP / 98
Orphenadrine hydrochloride I SEP / 98
Oseltamivir or its saltsPDL I DEC / 13
Osimertinib or its saltsPDL I AUG / 16
Oxabolone and its derivativesC3 I SEP / 98
Oxacillin, or its salts or derivativesPDL

For veterinary use

I DEC / 13
OxaliplatinPDL I DEC / 13
OxanamidePDL I DEC / 13
OxandroloneC3 I JUN / 02
Oxaprozin or its salts or derivativesPDL I DEC / 13
Oxazepam and its saltsTS I SEP / 98
OxazolamTS I JUN / 02
OxcarbazepinePDL I DEC / 13
Oxethazine III SEP / 98
Oxiconazole 1% for topical use U SEP / 99
Oxolinic acid or its saltsPDL I DEC / 13
Oxprenolol or its saltsPDL I DEC / 13
Oxybuprocaine and its salts benoxinate for opthalmic or parenteral use II SEP / 98
Oxybuprocaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Oxybutynin or its saltsPDL I DEC / 13
OxycodoneN I JUN / 02
OxymesteroneC3 I JUN / 02
Oxymetazoline in nasal preparations for adult use and in ophthalmic products U
Oxymetazoline and its salts in nasal preparations for pediatric use II SEP / 98
OxymetholoneC3 I JUN / 02
OxymorphoneN I JUN / 02
Oxyphenbutazone or its saltsPDL I DEC / 13
Oxyquinoline II SEP / 98
Oxytetracycline or its saltsPDL

For veterinary use
 

I DEC / 18
OxytocinPDL I DEC / 13
Ozenoxacin or its saltsPDL I JUN / 17

60 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled